Do you think it would be worth investing in Cortex Pharmaceuticals? There AMPAKINE CX717 is nearly in phase III, and they've recently received UK regulatory approval to initiate a clinical study in sleep apnea with there AMPAKINE CX1739.
Trading on the NYSE, btw
FinancialContent.com - Stock Quotes and Business News
Cortex


Reply With Quote
